A Retrospective Clinical Analysis of Multiple Myeloma Patients with Cardiac Amyloidosis.
10.19746/j.cnki.issn.1009-2137.2025.03.031
- Author:
Tian-Yue BIAN
1
;
Shun WANG
2
;
Qun LU
2
;
Shi-Hui YUAN
1
;
Rui LI
1
;
Rui XU
1
;
Ying CHEN
1
;
Hua-Sheng LIU
1
Author Information
1. Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061, Shaanxi Province, China.
2. Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China.
- Publication Type:Journal Article
- Keywords:
abnormal immunoglobulin light chain;
cardiac amyloidosis;
prognostic factors;
retrospective analysis
- MeSH:
Humans;
Multiple Myeloma/complications*;
Retrospective Studies;
Aged;
Female;
Male;
Middle Aged;
Prognosis;
Hematopoietic Stem Cell Transplantation;
Amyloidosis/complications*;
Survival Rate;
Proportional Hazards Models
- From:
Journal of Experimental Hematology
2025;33(3):834-840
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the clinical characteristics, curative effect and prognostic factors of patients with multiple myeloma (MM) complicated with light chain myocardial amyloidosis (AL-CA).
METHODS:The data of 38 patients diagnosed with MM complicated with AL-CA in our hospital from January 2018 to December 2023 were retrospectively analyzed, and the data were comprehensively screened by multiple methods such as positive two-dimensional spot tracking echocardiography (2D-STE). Survival analysis was performed using the Kaplan-Meier method. Cox regression models were used to screen for independent prognostic factors.
RESULTS:Among the 38 MM patients with AL-CA, 23 were male and 15 were female, with a median age of 60(50,75) years. The 1-year survival rate was 71.05%. Patients who underwent transplantation had significantly better survival outcomes than those who did not (P < 0.01). Additionally, the median survival time of patients with all-negative FISH results at the first visit was statistically different compared to patients with other mutations (P < 0.05). Multivariate Cox regression analysis showed that all negative FISH results at the first visit and the absence of autologous hematopoietic stem cell transplantation (ASCT) were not independent risk factor for the prognosis of patients with MM and AL-CA (P >0.05).
CONCLUSION:ASCT may improve the prognosis of MM patients with AL-CA, and negative FISH results may indicate poor prognosis, but the results still need to be verified by larger samples.
